Mobile

A phase II, single-center, randomized, controlled, observer-blind study to determine the non-inferiority of a topical mometasone formulation vs a marketed comparator by evaluation of the anti-psoriati...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-002141-24

A phase II, single-center, randomized, controlled, observer-blind study to determine the non-inferiority of a topical mometasone formulation vs a marketed comparator by evaluation of the anti-psoriatic efficacy in a psoriasis plaque test

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the non-inferiority of a new topical corticsteroid formulation vs the marketed product Ecural® Fettcreme in a psoriasis plaque test

Critère d'inclusion

  • volunteers with psoriasis vulgaris in a cronic stable phase and stable plaques with an area sufficient for 3 treatment fields

Liens